Loading...

PROTAGENIC THERAPEUTICS INC Delisting Actions 8-K Filing

PRTG

PROTAGENIC THERAPEUTICS INC

()

2026 8-K

Leadership Appointment

Stock Delisting Notice

Delisting Notification

Director Resignation

Legal Action Filed

Acquisition Update

Company Acquisition

Accounting Changes

Restructuring Plan

Rights Offerings

Warrant Exercises

Warrant Exchange

Asset Acquisitions

Stock Split Approval

Stock Option Repricing

Annual Meeting Results

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Update

Filing with Quantitative Data

Quantitative Data

Annual Meeting Results

Quantitative Data

Reverse Stock Split

External Links:

Protagenic Therapeutics, Inc. announced that its common stock and warrants will be delisted from Nasdaq on January 2, 2026, due to failure to meet listing requirements as of December 31, 2025, and will instead trade on the OTC market starting January 5, 2026. The company plans to continue filing reports with the SEC and is evaluating steps to regain compliance with Nasdaq.

AI Assistant

PROTAGENIC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.